rs760737807

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP6_Very_Strong

The NM_000368.5(TSC1):​c.2626-3_2626-2insT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000448 in 914,826 control chromosomes in the GnomAD database, with no homozygous occurrence. There is a variant allele frequency bias in the population database for this variant (GnomAdExome4), which may indicate mosaicism or somatic mutations in the reference population data. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000069 ( 0 hom., cov: 14)
Exomes 𝑓: 0.00047 ( 0 hom. )

Consequence

TSC1
NM_000368.5 splice_region, intron

Scores

Not classified

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.387

Publications

0 publications found
Variant links:
Genes affected
TSC1 (HGNC:12362): (TSC complex subunit 1) This gene is a tumor suppressor gene that encodes the growth inhibitory protein hamartin. The encoded protein interacts with and stabilizes the GTPase activating protein tuberin. This hamartin-tuberin complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. This protein also functions as a co-chaperone for Hsp90 that inhibits its ATPase activity. This protein functions as a facilitator of Hsp90-mediated folding of kinase and non-kinase clients, including TSC2 and thereby preventing their ubiquitination and proteasomal degradation. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC1 Gene-Disease associations (from GenCC):
  • tuberous sclerosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • tuberous sclerosis 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • lung lymphangioleiomyomatosis
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • tuberous sclerosis complex
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP6
Variant 9-132897612-T-TA is Benign according to our data. Variant chr9-132897612-T-TA is described in ClinVar as Likely_benign. ClinVar VariationId is 802523.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSC1NM_000368.5 linkc.2626-3_2626-2insT splice_region_variant, intron_variant Intron 20 of 22 ENST00000298552.9 NP_000359.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSC1ENST00000298552.9 linkc.2626-3_2626-2insT splice_region_variant, intron_variant Intron 20 of 22 1 NM_000368.5 ENSP00000298552.3
TSC1ENST00000490179.4 linkc.2626-3_2626-2insT splice_region_variant, intron_variant Intron 21 of 23 3 ENSP00000495533.2

Frequencies

GnomAD3 genomes
AF:
0.0000687
AC:
3
AN:
43664
Hom.:
0
Cov.:
14
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00169
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000676
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000336
AC:
39
AN:
116050
AF XY:
0.000285
show subpopulations
Gnomad AFR exome
AF:
0.000227
Gnomad AMR exome
AF:
0.00110
Gnomad ASJ exome
AF:
0.000709
Gnomad EAS exome
AF:
0.00112
Gnomad FIN exome
AF:
0.000130
Gnomad NFE exome
AF:
0.000117
Gnomad OTH exome
AF:
0.000890
GnomAD4 exome
AF:
0.000467
AC:
407
AN:
871124
Hom.:
0
Cov.:
27
AF XY:
0.000481
AC XY:
211
AN XY:
438666
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000382
AC:
9
AN:
23534
American (AMR)
AF:
0.000924
AC:
21
AN:
22720
Ashkenazi Jewish (ASJ)
AF:
0.000390
AC:
6
AN:
15372
East Asian (EAS)
AF:
0.000737
AC:
22
AN:
29832
South Asian (SAS)
AF:
0.00177
AC:
74
AN:
41816
European-Finnish (FIN)
AF:
0.000698
AC:
20
AN:
28642
Middle Eastern (MID)
AF:
0.000311
AC:
1
AN:
3220
European-Non Finnish (NFE)
AF:
0.000352
AC:
235
AN:
668560
Other (OTH)
AF:
0.000508
AC:
19
AN:
37428
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.322
Heterozygous variant carriers
0
24
48
71
95
119
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000686
AC:
3
AN:
43702
Hom.:
0
Cov.:
14
AF XY:
0.0000491
AC XY:
1
AN XY:
20368
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
17812
American (AMR)
AF:
0.00
AC:
0
AN:
3378
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
714
East Asian (EAS)
AF:
0.00170
AC:
2
AN:
1178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
862
European-Finnish (FIN)
AF:
0.000676
AC:
1
AN:
1480
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
78
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
17422
Other (OTH)
AF:
0.00
AC:
0
AN:
546
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Tuberous sclerosis 1 Benign:2
May 28, 2019
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Tuberous sclerosis syndrome Benign:1
Nov 20, 2023
All of Us Research Program, National Institutes of Health
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.39

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs760737807; hg19: chr9-135772999; COSMIC: COSV53765632; COSMIC: COSV53765632; API